{
    "nct_id": "NCT04713657",
    "official_title": "Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In Tetralogy of Fallot",
    "inclusion_criteria": "* Male and female infants < 45 days of age with a diagnosis of tetralogy of Fallot with pulmonary stenosis or double outlet right ventricle, tetralogy type by echocardiogram, who weigh greater than 2 kg at the time of consent and are tolerating enteral feeds.\n* DORV variant\nHealthy volunteers allowed\nMust have minimum age of 30 Days\nMust have maximum age of 44 Days",
    "exclusion_criteria": "* congenital atrio-ventricular block on EKG (PR interval > 120 ms),\n* concomitant medication administration that interacts with propranolol,\n* patient family is, in the opinion of the investigator, unable to comply with the requirements of the study protocol or is unsuitable for the study for any reason,\n* gestation age < 35 weeks,\n* infants of diabetic mothers, asthma or underlying respiratory disease,\n* presence of metal implants in infants.",
    "miscellaneous_criteria": ""
}